4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade.
Medchemcomm
; 8(9): 1850-1855, 2017 Sep 01.
Article
in En
| MEDLINE
| ID: mdl-30108896
ABSTRACT
The NF-κB signaling pathway is a validated oncological target. Here, we applied scaffold hopping to IMD-0354, a presumed IKKß inhibitor, and identified 4-hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide (4) as a nM-inhibitor of the NF-κB pathway. However, both 4 and IMD-0354, being potent inhibitors of the canonical NF-κB pathway, were found to be inactive in human IKKß enzyme assays.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Medchemcomm
Year:
2017
Type:
Article
Affiliation country:
Italy